Global Left Ventricular Assist Device (LVAD) Market - Industry Trends and Forecast to 2029

Global Left Ventricular Assist Device (LVAD) Market - Industry Trends and Forecast to 2029

Global left ventricular assist device (LVAD) market is projected to register a CAGR of 9.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation:
Global Left Ventricular Assist Device (LVAD) Market, By Product Type (Heart Pump, Controller, Batteries, Wires), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy, Bridge-To-Recovery (BTR) Therapy), Age Group (Adult, Pediatric), Indication (Congestive Heart Failure, Congenital Heart Disease, Myocarditis, Cardiac Arrest, Familial Arrhythmias and Arrhythmic, Cardiomyopathies, Advanced Heart Failure, Others), Generation (Second Generation Devices, Third Generation Devices, First Generation Devices), Durability (Long-Term, Intermediate-Term, Short-Term), Design (Axial, Centrifugal), Pulse Type (Nonpulsatile, Pulsatile), End User (Hospitals, Cardiac Cath Laboratories, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel and Rest of Middle East And Africa, Brazil, Argentina and Rest of South America) Industry Trends and Forecast to 2029


Some of the major factors contributing to the growth of the global left ventricular assist device (LVAD) market are:

. Increasing geriatric population along with rising prevalence of cardiac diseases
. Presence of favorable reimbursement policies

Market Players:

The key market players for global left ventricular assist device (LVAD) market are listed below:

. Abbott
. Evaheart, Inc
. Saft (A Subsidiary of TotalEnergies)
. ABIOMED
. Berlin Heart
. CorWave SA
. Jarvik Heart, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.